Search Results 2071-2080 of 18531 for ectopic-pregnancy

1. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

   Not pregnant and not nursing ... For women of childbearing potential only, a negative pregnancy test done ≤ 5 days prior to registration is required.

2. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this trial, the treating physician should be informed ...

3. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

   Female patients of childbearing potential must have a negative serum beta-human chorionic gonadotropin (β-hCG) pregnancy test within 28 days prior to the start ...

4. Learning More about How your Brain Works with Decreased Levels of Oxygen - Mayo Clinic

   If female and of child bearing potential, have a negative pregnancy test prior (within 48 hours) to participating in the study. ... Females who are pregnant.

5. A Study of BI-RADS 4 and 5 Lesions that are Malignant and Increased Stiffness on MR Elastography Compared to Lesions that are Benign - Mayo Clinic

   Pregnant and lactating females will be excluded (Women of child bearing potential will have a urine pregnancy test administered prior to the MR elastography ...

6. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Negative pregnancy test done ≤ 7 days prior to registration, for persons of childbearing potential only. Persons able to become pregnant OR able to father ...

7. A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Women of childbearing potential must have negative blood or urine pregnancy test at screening. Exclusion Criteria: Recent therapeutic interventions within 3 ...

8. A Study to assess the Safety of NRL-1 for the Treatment of People with Epilepsy - Mayo Clinic

   ... pregnancy screen and agree to utilize one of the following forms of contraception during the trial and for 21 days after the last dose of study drug.

9. A Study to Compare Techneagas® and Xenon 133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy - Mayo Clinic

   Subject has been administered any other radiopharmaceutical within a timeframe that might cause interference with study imaging. · Subject is a pregnant or ...

10. Mayo Clinic Transplant Center - Doctors

    ... pregnancy, Heart transplant complication, Postpartum cardiomyopathy, Circulatory death. Show more areas of focus for Ruben J. Crespo-Diaz, M.D., Ph.D.